SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001737287-22-000051
Filing Date
2022-07-12
Accepted
2022-07-12 16:09:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A allo-20220712xsctoxiamendm.htm SC TO-I/A 41679
  Complete submission text file 0001737287-22-000051.txt   43222
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filed by) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-90685 | Film No.: 221079283
SIC: 2836 Biological Products, (No Diagnostic Substances)